Carmel Wroth
Carmel Wroth is a senior health editor for NPR's Science Desk, where she guides digital strategy for the health team and conceives and edits digital-first, enterprise stories and packages.
Formerly, she founded and managed Side Effects Public Media, a public radio collaborative covering public health in the Midwest. Wroth also served as an editor at Yoga Journal for five years.
-
The influential US Preventive Services Task Force urged behavioral counseling for children and teens with very high BMI. Notably the group did not include Ozempic-like drugs in the recommendation. -
A new survey finds more people are surviving lung cancer and racial disparities are shrinking. But unless it's caught early, lung cancer still has a low survival rate. -
After years of high rates, the country hit a new high during the pandemic, far exceeding rates in other developed nations. Black women are at especially high risk. -
After years of high rates, the country hit a new high during the pandemic, far exceeding rates in other developed nations. Black women are at especially high risk.
-
Mental health advocates applaud the proposals, which they say offer much-needed federal leadership on a growing national crisis. But they worry about getting sustainable funding for the efforts. -
The federal health agency released new guidance for when Americans need to mask up indoors, saying about 70% of the population lives in a place where it's safe to go mask free.
-
You might want to cancel that holiday party, and definitely dust off your face mask. Don't panic, but do step up your precautions. Here's how. -
Roughly 175,000 children in the U.S. have lost one or both parents or a grandparent caregiver to COVID-19, according to a new study. The majority come from racial and ethnic minority groups. -
Though infections are still sky-high, the U.S. may be turning a corner, according to a consortium of researchers who forecast the pandemic. And we may well be spared a winter surge. -
If all goes to plan, Americans who got Pfizer or Moderna shots can get a third dose eight months after their last jab. Here's why health officials think you'll need one.
